Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
+1.89%
SPX
+1.52%
IXIC
+1.88%
FTSE
+0.13%
N225
+0.05%
AXJO
-0.57%
Cashu Logo
Log In
HomeWatchlistNewsSignalsPicks
Stocks
0.00 (0.00%)
0.000
USD
At close at --,----
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.

Join our newsletter to keep up to date with us!

Overview

Loading chart...

Recently from Cashu

publisher logo
Cashu

AMGEN's Biotech Innovations Transforming Autoimmune Disease Treatment and Patient Care

3 days ago
publisher logo
Cashu

AMGEN Leads Innovative Therapies for Autoimmune Disorders in Biotechnology's Transformative Era

5 days ago
publisher logo
Cashu

Amgen's Legal Battle Reflects Growing Tensions Over Drug Pricing and Government Regulations

15 days ago

About

What does AMGN do?
Amgen, headquartered in Thousand Oaks, California, is a biotechnology company employing 26,700 staff, focusing on developing human therapeutics for high unmet medical needs. Its product portfolio includes Aranesp, ENBREL, and Prolia, among others.
Sector
💻 Health Care
IPO
CEO
Employees
28,000
Headquarters
California, USA
Website
http://www.amgen.com

Key Stats

Market Cap
157.94B
Dividend Yield
0.00%
P/E Ratio
23.86
EPS
7.62
Revenue
33.42B
Avg. Volume
1.76M
Stocks
Health Care
amgn
AMGEN
NASDAQ: AMGN
-2.15 (-0.73%)
293.605
USD
At close at Aug 22, 20:34 UTC
Summary
News
Signals
Benchmarks
Financials